Department of Experimental Medicine (DIMES) University of Genova, Genova, Italy.
PLoS One. 2012;7(8):e44518. doi: 10.1371/journal.pone.0044518. Epub 2012 Aug 31.
Extracellular high mobility group box 1 (HMGB1) protein can operate in a synergistic fashion with different signal molecules promoting an increase of cell Ca(2+) influx. However, the mechanisms responsible for this effect of HMGB1 are still unknown.
Here we demonstrate that, at concentrations of agonist per se ineffective, HMGB1 potentiates the activation of the ionotropic glutamate N-methyl-D-aspartate receptor (NMDAR) in isolated hippocampal nerve terminals and in a neuroblastoma cell line. This effect was abolished by the NMDA channel blocker MK-801. The HMGB1-facilitated NMDAR opening was followed by activation of the Ca(2+)-dependent enzymes calpain and nitric oxide synthase in neuroblastoma cells, resulting in an increased production of NO, a consequent enhanced cell motility, and onset of morphological differentiation. We have also identified NMDAR as the mediator of HMGB1-stimulated murine erythroleukemia cell differentiation, induced by hexamethylenebisacetamide. The potentiation of NMDAR activation involved a peptide of HMGB1 located in the B box at the amino acids 130-139. This HMGB1 fragment did not overlap with binding sites for other cell surface receptors of HMGB1, such as the advanced glycation end products or the Toll-like receptor 4. Moreover, in a competition assay, the HMGB1((130-139)) peptide displaced the NMDAR/HMGB1 interaction, suggesting that it comprised the molecular and functional site of HMGB1 regulating the NMDA receptor complex.
We propose that the multifunctional cytokine-like molecule HMGB1 released by activated, stressed, and damaged or necrotic cells can facilitate NMDAR-mediated cell responses, both in the central nervous system and in peripheral tissues, independently of other known cell surface receptors for HMGB1.
细胞外高迁移率族蛋白 B1(HMGB1)蛋白可以与不同的信号分子协同作用,促进细胞内 Ca(2+)内流增加。然而,HMGB1 产生这种作用的机制尚不清楚。
在这里,我们证明,在浓度本身对受体无作用的情况下,HMGB1 可增强分离的海马神经末梢和神经母细胞瘤细胞系中离子型谷氨酸 N-甲基-D-天冬氨酸受体(NMDAR)的激活。这种作用被 NMDA 通道阻滞剂 MK-801 所阻断。HMGB1 促进的 NMDAR 开放随后导致神经母细胞瘤细胞中 Ca(2+)依赖性酶钙蛋白酶和一氧化氮合酶的激活,导致 NO 产量增加,细胞迁移增强,并出现形态分化。我们还确定 NMDAR 是 HMGB1 刺激 hexamethylenebisacetamide 诱导的鼠红白血病细胞分化的介质。NMDAR 激活的增强涉及 HMGB1 中位于氨基酸 130-139 的 B 盒中的肽。该 HMGB1 片段不与 HMGB1 的其他细胞表面受体(如晚期糖基化终产物或 Toll 样受体 4)的结合位点重叠。此外,在竞争测定中,HMGB1((130-139)) 肽置换了 NMDAR/HMGB1 相互作用,表明它包含调节 NMDA 受体复合物的 HMGB1 的分子和功能位点。
我们提出,激活、应激、损伤或坏死细胞释放的多功能细胞因子样分子 HMGB1 可以促进中枢神经系统和外周组织中 NMDAR 介导的细胞反应,而与其他已知的 HMGB1 细胞表面受体无关。